Logo image of ANTA

ANTALPHA PLATFORM HLDNG CO-A (ANTA) Stock Fundamental Analysis

NASDAQ:ANTA - KYG0395R1065 - Common Stock

13.24 USD
-0.21 (-1.56%)
Last: 8/27/2025, 11:09:50 AM
12.8001 USD
-0.44 (-3.32%)
After Hours: 8/13/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, ANTA scores 3 out of 10 in our fundamental rating. ANTA was compared to 53 industry peers in the Consumer Finance industry. ANTA has a bad profitability rating. Also its financial health evaluation is rather negative. ANTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ANTA was profitable.
ANTA had a negative operating cash flow in the past year.
ANTA Yearly Net Income VS EBIT VS OCF VS FCFANTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -5M -10M

1.2 Ratios

ANTA has a Return On Assets of 0.35%. This is in the lower half of the industry: ANTA underperforms 66.04% of its industry peers.
Looking at the Return On Equity, with a value of 9.47%, ANTA is in line with its industry, outperforming 49.06% of the companies in the same industry.
With a Return On Invested Capital value of 1.07%, ANTA perfoms like the industry average, outperforming 45.28% of the companies in the same industry.
Industry RankSector Rank
ROA 0.35%
ROE 9.47%
ROIC 1.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANTA Yearly ROA, ROE, ROICANTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -20 -40

1.3 Margins

The Profit Margin of ANTA (9.26%) is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 6.70%, ANTA is in line with its industry, outperforming 49.06% of the companies in the same industry.
ANTA's Gross Margin of 48.12% is in line compared to the rest of the industry. ANTA outperforms 45.28% of its industry peers.
Industry RankSector Rank
OM 6.7%
PM (TTM) 9.26%
GM 48.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANTA Yearly Profit, Operating, Gross MarginsANTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

ANTA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ANTA has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ANTA has been reduced compared to a year ago.
ANTA Yearly Shares OutstandingANTA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M
ANTA Yearly Total Debt VS Total AssetsANTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ANTA has an Altman-Z score of 0.25. This is a bad value and indicates that ANTA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ANTA (0.25) is worse than 62.26% of its industry peers.
ANTA has a Debt/Equity ratio of 2.76. This is a high value indicating a heavy dependency on external financing.
ANTA has a Debt to Equity ratio (2.76) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACC0.12
WACC8.56%
ANTA Yearly LT Debt VS Equity VS FCFANTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M

2.3 Liquidity

ANTA has a Current Ratio of 1.05. This is a normal value and indicates that ANTA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.05, ANTA is in line with its industry, outperforming 49.06% of the companies in the same industry.
ANTA has a Quick Ratio of 1.05. This is a normal value and indicates that ANTA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ANTA (1.05) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ANTA Yearly Current Assets VS Current LiabilitesANTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

ANTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 166.71%, which is quite impressive.
Looking at the last year, ANTA shows a very strong growth in Revenue. The Revenue has grown by 320.96%.
EPS 1Y (TTM)166.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)320.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ANTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.81% yearly.
Based on estimates for the next years, ANTA will show a very strong growth in Revenue. The Revenue will grow by 38.94% on average per year.
EPS Next Y103.79%
EPS Next 2Y141.77%
EPS Next 3Y65.81%
EPS Next 5YN/A
Revenue Next Year63.16%
Revenue Next 2Y51.6%
Revenue Next 3Y38.94%
Revenue Next 5YN/A

3.3 Evolution

ANTA Yearly Revenue VS EstimatesANTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ANTA Yearly EPS VS EstimatesANTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 69.68, which means the current valuation is very expensive for ANTA.
Based on the Price/Earnings ratio, ANTA is valued more expensive than 81.13% of the companies in the same industry.
When comparing the Price/Earnings ratio of ANTA to the average of the S&P500 Index (27.08), we can say ANTA is valued expensively.
The Price/Forward Earnings ratio is 11.91, which indicates a very decent valuation of ANTA.
ANTA's Price/Forward Earnings ratio is in line with the industry average.
ANTA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 69.68
Fwd PE 11.91
ANTA Price Earnings VS Forward Price EarningsANTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ANTA is valued a bit more expensive than the industry average as 62.26% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 177.59
ANTA Per share dataANTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ANTA's earnings are expected to grow with 65.81% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y141.77%
EPS Next 3Y65.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ANTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTALPHA PLATFORM HLDNG CO-A

NASDAQ:ANTA (8/27/2025, 11:09:50 AM)

After market: 12.8001 -0.44 (-3.32%)

13.24

-0.21 (-1.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.58%
Ins Owner ChangeN/A
Market Cap305.84M
Analysts85
Price Target19.64 (48.34%)
Short Float %1.06%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 69.68
Fwd PE 11.91
P/S 6.44
P/FCF N/A
P/OCF N/A
P/B 6.59
P/tB 6.59
EV/EBITDA 177.59
EPS(TTM)0.19
EY1.44%
EPS(NY)1.11
Fwd EY8.4%
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS2.05
BVpS2.01
TBVpS2.01
PEG (NY)0.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 9.47%
ROCE 1.2%
ROIC 1.07%
ROICexc 1.09%
ROICexgc 1.09%
OM 6.7%
PM (TTM) 9.26%
GM 48.12%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF N/A
Debt/EBITDA 31.95
Cap/Depr 19.28%
Cap/Sales 0.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.25
F-Score6
WACC8.56%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y103.79%
EPS Next 2Y141.77%
EPS Next 3Y65.81%
EPS Next 5YN/A
Revenue 1Y (TTM)320.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year63.16%
Revenue Next 2Y51.6%
Revenue Next 3Y38.94%
Revenue Next 5YN/A
EBIT growth 1Y141.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year463.36%
EBIT Next 3Y126.9%
EBIT Next 5YN/A
FCF growth 1Y3.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.46%
OCF growth 3YN/A
OCF growth 5YN/A